Stockreport

LEO Pharma Presents Late-Breaking Anzupgo® (delgocitinib) Cream Presentation at EADV 2024 Highlighting Results of Head-to-Head DELTA FORCE Trial in Chronic Hand Eczema (CHE) [Yahoo! Financ...

JAPAN TOBACCO UNSP/ADR  (JAPAY) 
NASDAQ:AMEX Investor Relations: gungho.co.jp/en/ir
PDF with delgocitinib cream had a significantly higher efficacy compared to oral alitretinoin capsules among adult patients with severe CHE. Six other pieces of investigat [Read more]